462 related articles for article (PubMed ID: 25137421)
1. Serum androgen levels in elite female athletes.
Bermon S; Garnier PY; Hirschberg AL; Robinson N; Giraud S; Nicoli R; Baume N; Saugy M; Fénichel P; Bruce SJ; Henry H; Dollé G; Ritzen M
J Clin Endocrinol Metab; 2014 Nov; 99(11):4328-35. PubMed ID: 25137421
[TBL] [Abstract][Full Text] [Related]
2. Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance.
Rickenlund A; Carlström K; Ekblom B; Brismar TB; von Schoultz B; Hirschberg AL
Fertil Steril; 2003 Apr; 79(4):947-55. PubMed ID: 12749436
[TBL] [Abstract][Full Text] [Related]
3. Androgen and SHBG serum concentrations in late post-menopause women.
Skałba P; Wójtowicz M; Sikora J
Med Sci Monit; 2003 Mar; 9(3):CR152-6. PubMed ID: 12640346
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women.
Allen SE; Potter HD; Azziz R
Fertil Steril; 1997 Mar; 67(3):569-72. PubMed ID: 9091350
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
6. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D
Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
De Leo V; Di Sabatino A; Musacchio MC; Morgante G; Scolaro V; Cianci A; Petraglia F
Contraception; 2010 Sep; 82(3):276-80. PubMed ID: 20705157
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
Sobbrio GA; Granata A; D'Arrigo F; Arena D; Panacea A; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):139-41. PubMed ID: 2149912
[TBL] [Abstract][Full Text] [Related]
9. Sex, age, pubertal development and use of oral contraceptives in relation to serum concentrations of DHEA, DHEAS, 17α-hydroxyprogesterone, Δ4-androstenedione, testosterone and their ratios in children, adolescents and young adults.
Søeborg T; Frederiksen H; Mouritsen A; Johannsen TH; Main KM; Jørgensen N; Petersen JH; Andersson AM; Juul A
Clin Chim Acta; 2014 Nov; 437():6-13. PubMed ID: 24976611
[TBL] [Abstract][Full Text] [Related]
10. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition.
Burger HG; Dudley EC; Cui J; Dennerstein L; Hopper JL
J Clin Endocrinol Metab; 2000 Aug; 85(8):2832-8. PubMed ID: 10946891
[TBL] [Abstract][Full Text] [Related]
11. Intrauterine growth retardation predisposes to insulin resistance but not to hyperandrogenism in young women.
Jaquet D; Leger J; Chevenne D; Czernichow P; Levy-Marchal C
J Clin Endocrinol Metab; 1999 Nov; 84(11):3945-9. PubMed ID: 10566632
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral versus transdermal steroidal contraceptives on androgenic markers.
White T; Jain JK; Stanczyk FZ
Am J Obstet Gynecol; 2005 Jun; 192(6):2055-9. PubMed ID: 15970897
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism.
Fénichel P; Paris F; Philibert P; Hiéronimus S; Gaspari L; Kurzenne JY; Chevallier P; Bermon S; Chevalier N; Sultan C
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1055-9. PubMed ID: 23633205
[TBL] [Abstract][Full Text] [Related]
14. Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels.
Lado-Abeal J; Rodriguez-Arnao J; Newell-Price JD; Perry LA; Grossman AB; Besser GM; Trainer PJ
J Clin Endocrinol Metab; 1998 Sep; 83(9):3083-8. PubMed ID: 9745407
[TBL] [Abstract][Full Text] [Related]
15. Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry.
Haring R; Hannemann A; John U; Radke D; Nauck M; Wallaschofski H; Owen L; Adaway J; Keevil BG; Brabant G
J Clin Endocrinol Metab; 2012 Feb; 97(2):408-15. PubMed ID: 22162468
[TBL] [Abstract][Full Text] [Related]
16. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
Vermeulen A; Kaufman JM; Giagulli VA
J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls.
Panidis D; Farmakiotis D; Koliakos G; Rousso D; Kourtis A; Katsikis I; Asteriadis C; Karayannis V; Diamanti-Kandarakis E
Hum Reprod; 2005 Aug; 20(8):2127-32. PubMed ID: 15890737
[TBL] [Abstract][Full Text] [Related]
18. Effect of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) on serum androgen markers in normal-weight, obese, and extremely obese women.
Segall-Gutierrez P; Du J; Niu C; Ge M; Tilley I; Mizraji K; Stanczyk FZ
Contraception; 2012 Dec; 86(6):739-45. PubMed ID: 22959905
[TBL] [Abstract][Full Text] [Related]
19. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
20. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of sexual dysfunction.
Guay A; Munarriz R; Jacobson J; Talakoub L; Traish A; Quirk F; Goldstein I; Spark R
Int J Impot Res; 2004 Apr; 16(2):112-20. PubMed ID: 14999217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
